Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy
Kai-Leng Tan, Han-Chung Lee, Pike-See Cheah, et al.
Neuroscience (2022) Vol. 511, pp. 1-12
Closed Access | Times Cited: 22

Showing 22 citing articles:

Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
Chiara Lanzillotta, Monika Rataj Baniowska, Francesca Prestia, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106523-106523
Open Access | Times Cited: 7
Brain Mitochondrial Bioenergetics in Genetic Neurodevelopmental Disorders: Focus on Down, Rett and Fragile X Syndromes
Daniela Valenti, Rosa Anna Vacca
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12488-12488
Open Access | Times Cited: 12
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease–A step towards mitochondria based therapeutic strategies
Khadga Raj Aran, Shamsher Singh
Aging and Health Research (2023) Vol. 3, Iss. 4, pp. 100169-100169
Open Access | Times Cited: 12
Epigenetic Control of Hyperuricemia and Gout by Gene Writer DNMT1 and RNA Editor ADAR1: Mechanism of Gout and Amyloid Dissolution in Down Syndrome
Suresh C. Tyagi, Irina Smolenkova, Yuting Zheng, et al.
Biochemical Genetics (2025)
Open Access
Human Models of Down Syndrome
Megan Jandy, Hao Hu, Yan Liu, et al.
(2025), pp. 233-267
Closed Access
The proteostasis burden of aneuploidy
Prince Saforo Amponsah, Zuzana Štorchová
Biological Chemistry (2025)
Closed Access
Mitochondrial transplantation: Triumphs, challenges, and impacts on nuclear genome remodelling
Elly H. Shin, Quinn Le, Rachel Barboza, et al.
Mitochondrion (2025), pp. 102042-102042
Closed Access
Premature aging in aneuploid yeast is caused in part by aneuploidy-induced defects in Ribosome Quality Control
Leah E. Escalante, James Hose, Hollis Howe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome
Csaba Szabó
Neurotherapeutics (2025), pp. e00584-e00584
Open Access
Mitochondrial Imbalance in Down Syndrome: A Driver of Accelerated Brain Aging?
Xinxin Zuo
Aging and Disease (2025)
Open Access
Reversing intellectual disabilities in Down syndrome: Hopes or hypes?
Christopher Thiam Seong Lim, Cheng Wei Lim, Pike-See Cheah, et al.
The Indian Journal of Medical Research (2025), pp. 1-4
Open Access
TransPhoM-DS Study Grant Report: Rationale and Protocol for Investigating the Efficacy of Low-Power Transcranial Photobiomodulation on Language, Executive Function, Attention, and Memory in Down Syndrome
Willians Fernando Vieira, David Richer Araujo Coelho, Maia B. Gersten, et al.
Photonics (2024) Vol. 11, Iss. 7, pp. 670-670
Open Access | Times Cited: 3
Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta
Jean Guibourdenche, Marie-Clémence Leguy, Guillaume Pidoux, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7669-7669
Open Access | Times Cited: 7
Intricacies of Aging and Down Syndrome
G. Kozlov, Claudio Franceschi, Maria V. Vedunova
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105794-105794
Closed Access | Times Cited: 2
SOD1 Is an Integral Yet Insufficient Oxidizer of Hydrogen Sulfide in Trisomy 21 B Lymphocytes and Can Be Augmented by a Pleiotropic Carbon Nanozyme
K. Chandra Mouli, Anton V. Liopo, Larry J. Suva, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1361-1361
Open Access | Times Cited: 2
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism of Protopanaxadiol Triphenylphosphate Derivative in Non-Small-Cell Lung Cancer
Han Liu, Xingbo Bian, Xiangyu Ma, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4275-4275
Open Access | Times Cited: 1
Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome
Xuehai Ma, Weimin Li, Jun Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
WITHDRAWN: Intricacies of aging and down syndrome
G. Kozlov, Claudio Franceschi, Maria V. Vedunova
Aspects of Molecular Medicine (2024), pp. 100035-100035
Open Access
Epigenetic Control of Hyperuricemia and Gout by Gene Writer DNMT1 and RNA Editor ADAR1: Mechanism of Gout and Amyloid Dissolution in Down Syndrome
Suresh C. Tyagi, Irina Smolenkova, Yuting Zheng, et al.
Research Square (Research Square) (2024)
Open Access
The Translocase of the Outer Mitochondrial Membrane (TOM40) is required for mitochondrial dynamics and neuronal integrity in Dorsal Root Ganglion Neurons
Caitlin Overmeyer, Kylie Jorgensen, Bhupinder P. S. Vohra
Molecular and Cellular Neuroscience (2023) Vol. 125, pp. 103853-103853
Closed Access | Times Cited: 1
Cognitive and molecular characterization of the Ts66Yah murine model of Down syndrome: deepening on hippocampal changes associated with genotype and aging
Chiara Lanzillotta, Monika Rataj Baniowska, Francesca Prestia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Realizing the potential of exploiting human IPSCs and their derivatives in research of Down syndrome
Y. Wang, JIELEI NI, YUHAN LIU, et al.
Biocell (2023) Vol. 47, Iss. 12, pp. 2567-2578
Open Access
Page 1

Scroll to top